SCAPHO Secukinumab 150mg Injection

Scapho 150mg (Secukinumab) is a prescription drug used  to treat psoriasis in adults. It is an immunosuppressant which works by reducing the effects of chemicals that cause inflammation.

Manufacturer : Novartis Pharma Stein AG Germany

Strengths available :  150mg

Storage :  Store at temperature between 2°C – 8°C

Dosage :

Plaque Psoriasis

The recommended dosage is 300 mg by subcutaneous injection at Weeks 0, 1, 2, 3, and 4 followed by 300 mg every 4 weeks. Each 300 mg dosage is given as 2 subcutaneous injections of 150 mg.

For some patients, a dosage of 150 mg may be acceptable.

Psoriatic Arthritis

For psoriatic arthritis patients with coexistent moderate to severe plaque psoriasis, use the dosing and administration

recommendations for plaque psoriasis [see Dosage and Administration (2.1)].

For other psoriatic arthritis patients, administer COSENTYX with or without a loading dosage by subcutaneous injection.

The recommended dosage:

• With a loading dosage is 150 mg at weeks 0, 1, 2, 3, and 4 and every 4 weeks thereafter
• Without a loading dosage is 150 mg every 4 weeks
• If a patient continues to have active psoriatic arthritis, consider a dosage of 300 mg.

COSENTYX may be administered with or without methotrexate.

 Ankylosing Spondylitis

Administer COSENTYX with or without a loading dosage by subcutaneous injection. The recommended dosage:

• With a loading dosage is 150 mg at weeks 0, 1, 2, 3, and 4 and every 4 weeks thereafter
• Without a loading dosage is 150 mg every 4 weeks.

Most common side effects are Redness, warmth, or swelling under your skin; cold sores, sores on your genital or anal area; painful skin sores; cough, shortness of breath, cough with red or pink mucus; increased urination, pain or burning when you urinate; sores or white patches in your mouth or throat (yeast infection or “thrush”); diarrhea, stomach pain; or fever, chills, sweating, muscle pain, weight loss.

Pack of 1 Vial